EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatoprotective effects of Scoparone in an experimental mouse model of liver fibrosis

Elçin Latife Kurtoğlu, Savaş Aslan, Safiye Göçer, Müjgan Özdemir Erdoğan, Saliha Handan Yıldız, Mustafa Solak

Health Sciences Quarterly · 27.04.2026 · 6 (2) · 345-353

DOI: 10.26900/hsq.3106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Sciences Quarterly, online erschienen am 27.04.2026. Verfasst von Elçin Latife Kurtoğlu und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scoparone, a key ingredient isolated from Artemisia capillaris, has important therapeutic properties. In our study, it was aimed to investigate the therapeutic effects of systemic administration of Scoparone on liver fibrosis after the formation of liver fibrosis with Thioacetamide. In order to create a chronic fibrosis model, Swiss albino mice were injected intraperitoneally with Thioacetamide. Serum levels of AST and ALT were investigated in all groups, and TGF-β1, HGF and TNFAIP6 gene expressions from mRNA isolated from liver tissues were examined. According to our findings; ALT and AST levels of mouse serum samples in the fibrosis groups were significantly increased compared to the control, DMSO and Scoparone groups. It was observed that Scoparone injection in the fibrosis group decreased ALT and AST levels, but there was no statistically significant difference. While HGF gene expression was found to be significantly higher in liver mRNA samples in which Scoparone treatment was applied to the fibrous group, compared to all other groups, Scoparone injection to the fibrotic subjects caused a decrease in TGF-β1 gene expression (p

Zitieren

APA

Kurtoğlu, E. L., Aslan, S., Göçer, S., Erdoğan, M. Ö., Yıldız, S. H., & Solak, M. (2026). Hepatoprotective effects of Scoparone in an experimental mouse model of liver fibrosis. Health Sciences Quarterly, 6(2), 345-353. https://doi.org/10.26900/hsq.3106

Vancouver

Kurtoğlu EL, Aslan S, Göçer S, Erdoğan MÖ, Yıldız SH, Solak M. Hepatoprotective effects of Scoparone in an experimental mouse model of liver fibrosis. Health Sciences Quarterly. 2026;6(2):345-353. doi:10.26900/hsq.3106

BibTeX
@article{Kurtolu2026,
  author = {Kurtoğlu, Elçin Latife and Aslan, Savaş and Göçer, Safiye and Erdoğan, Müjgan Özdemir and Yıldız, Saliha Handan and Solak, Mustafa},
  title = {Hepatoprotective effects of Scoparone in an experimental mouse model of liver fibrosis},
  journal = {Health Sciences Quarterly},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {345--353},
  doi = {10.26900/hsq.3106}
}
Kostenlos starten →